• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA EXCHANGE SET Back to Search Results
Catalog Number 10225
Device Problems Obstruction of Flow (2423); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/05/2020
Event Type  malfunction  
Manufacturer Narrative
Investigation: one used and one unused astotube blood warming tubing was returned to terumo bct for evaluation.The used astotube had an extra piece of tubing connected which contained a shut off valve.The luer end connected to the optia return line was rf sealed and removed.Visual inspection of the used tubing confirmed there was small pockets of air interspersed throughout the tubing.Per the customer, the blood warmer was regulated/set to 37°c.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that one hour into an apheresis procedure, they noted bubbles in the blood warmer tubing.Per the customer, the bubbles were observed where the patient had been injected.They decided to remove blood warmer and then finished the procedure without the warmer and no further issues occured.Per the customer, no serious injury occured and no medical intervention was required for the event.Patient information is not available at this time.This product is not available within the us, but this report is being filed due to an alleged failure that could occur on a similarly marketed device platform cleared for use by the fda.
 
Event Description
During follow-up with the customer, it was reported that the type of procedure was erythrocyte exchange and there were no alarms occured during the run for air and the sample bag was not inflated.There was medical consultation done for this event by a physician a the customer site.There was no air being drawn in through the ac filter and there was no clotting in the channel or reservoir.
 
Manufacturer Narrative
Investigation is in process.A follow up report will be provided.
 
Event Description
Due to eu personal data protection laws, the patient identifier is not available from the customer.
 
Manufacturer Narrative
Investigation: a review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.The run data file (rdf) was analyzed for this event.Review of the relevant dlog confirmed the rbc exchange was completed successfully with only one alarm ("return pressure was too" high alarm.No "air in the return tubing" alarm(s) were generated, indicating that air in the blood warmer tubing was generated downstream of the rlad, which is consistent with outgassing of blood.Root cause: based on the investigation, the root cause of the air bubbles noted in blood warmer tubing may be related to outgassing.During exchange procedures on spectra optia, the replacement fluids may be cold.If they are not allowed to warm to room temperature, and if the return blood is warmed, air bubbles may form.The reason for this "outgassing" is that gasses are more soluble in liquids at low temperatures than at higher temperatures.If at a low storage temperature air is available to dissolve in a fluid and approaches its equilibrium solubility at that temperature, when the fluid is warmed the air will come out of solution, because its solubility is exceeded at the higher temperature.It is typically described as chains of very small bubbles or foam, which tend to rise toward the top of the tubing.The small bubbles may coalesce to form larger bubbles.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA EXCHANGE SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
MDR Report Key9769870
MDR Text Key185697961
Report Number1722028-2020-00086
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 02/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/01/2021
Device Catalogue Number10225
Device Lot Number1909233230
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/14/2020
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 02/06/2020
Initial Date FDA Received02/28/2020
Supplement Dates Manufacturer Received05/26/2020
09/28/2020
Supplement Dates FDA Received05/29/2020
09/29/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
BLOOD WARMER: ASTOTUBE (IFT 40410), BATCH 32415108.
Patient Outcome(s) Other;
Patient Age00042 YR
Patient Weight78
-
-